These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 (ATF3). Wu C; Lin H; Zhang X Int Immunopharmacol; 2019 Sep; 74():105700. PubMed ID: 31228816 [TBL] [Abstract][Full Text] [Related]
47. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease. Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002 [TBL] [Abstract][Full Text] [Related]
48. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis. Olson AL; Patnaik P; Hartmann N; Bohn RL; Garry EM; Wallace L Adv Ther; 2021 Jul; 38(7):4100-4114. PubMed ID: 34156606 [TBL] [Abstract][Full Text] [Related]
52. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? de Lauretis A; Veeraraghavan S; Renzoni E Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375 [TBL] [Abstract][Full Text] [Related]
56. [Interstitial lung diseases among patients hospitalized in the Department of Respiratory Medicine in Radom District Hospital during the years 2000-2009]. Szafrański W Pneumonol Alergol Pol; 2012; 80(6):523-32. PubMed ID: 23109204 [TBL] [Abstract][Full Text] [Related]
57. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD). Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M Front Immunol; 2020; 11():1990. PubMed ID: 33013852 [TBL] [Abstract][Full Text] [Related]
58. The natural history of progressive fibrosing interstitial lung diseases. Kolb M; Vašáková M Respir Res; 2019 Mar; 20(1):57. PubMed ID: 30871560 [TBL] [Abstract][Full Text] [Related]
59. Using Quantitative Computed Tomographic Imaging to Understand Chronic Obstructive Pulmonary Disease and Fibrotic Interstitial Lung Disease: State of the Art and Future Directions. Castillo-Saldana D; Hague CJ; Coxson HO; Ryerson CJ J Thorac Imaging; 2020 Jul; 35(4):246-254. PubMed ID: 31397750 [TBL] [Abstract][Full Text] [Related]
60. Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases. Tanguy J; Pommerolle L; Garrido C; Kolb M; Bonniaud P; Goirand F; Bellaye PS Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]